Dr. Stahl is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2525 S Downing St
Denver, CO 80210Phone+1 303-788-1955
Summary
- Dr. John Stahl is a radiation oncologist in Denver, CO. He received his medical degree from the University of Florida College of Medicine and has been in practice for more than 4 years. He is experienced in general radiation oncology, stereotactic radiosurgery, and stereotactic body radiotherapy. He has more than 20 publications and over 450 citings.
Education & Training
Yale-New Haven Medical CenterResidency, Radiation Oncology, 2014 - 2018
University of Florida College of Medicine2009-2013 M.D., Cum Laude
Vanderbilt UniversityBA, Molecular and Cellular Biology, Summa Cum Laude, 2005 - 2009
Certifications & Licensure
CO State Medical License 2022 - 2025
AL State Medical License 2018 - 2022
CT State Medical License 2015 - 2018- American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- Roentgen Resident/Fellow Research Award RSNA, 2018
Publications & Presentations
PubMed
- A focused review of statistical practices for relating radiation dose-volume exposure and toxicity.Andrew M McDonald, Craig S Schneider, John M Stahl, Robert A Oster, Richard A Popple
Radiation Oncology. 2023-03-24 - 6 citationsPrediction of Distant Metastases After Stereotactic Body Radiation Therapy for Early Stage NSCLC: Development and External Validation of a Multi-Institutional Model.Sarah J Gao, Lan Jin, Hugh W Meadows, Timothy D Shafman, Cary P Gross
Journal of Thoracic Oncology. 2023-03-01 - Patterns of Failure and Optimal Treatment Paradigm for Large, Inoperable, Node-Negative Non-small Cell Lung Cancer.Craig S Schneider, Haris Hatic, Devika Das, Rex A Cardan, John M Stahl
Clinical Lung Cancer. 2022-11-01
Press Mentions
Yale Researchers Identify Optimal Therapy for Patients with Early-Stage Glottic Cancer (Vocal Chord Cancer)April 26th, 2017
Professional Memberships
- Member
- American Society for Radiation Oncology (ASTRO)Member
- American Radium Society (ARS)Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
